Last reviewed · How we verify
Bivalirudin Injection
Bivalirudin Injection is a Small molecule drug developed by Hamad Medical Corporation. It is currently FDA-approved. Also known as: anticoagulation.
At a glance
| Generic name | Bivalirudin Injection |
|---|---|
| Also known as | anticoagulation |
| Sponsor | Hamad Medical Corporation |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Bivalirudin With Prolonged Full Dose Infusion Versus Heparin Alone During Emergency PCI (NA)
- A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation. (PHASE4)
- Bivalirudin with Prolonged Infusion During PCI Versus Heparin After Fibrinolytic Therapy (NA)
- Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCI (PHASE4)
- Safety and Efficacy of Bivalirudin During Short-term Intervention of Non-infarction Related Artery After PPCI of STEMI (NA)
- Reduce Bolus Injection of Bivalirudin (PHASE4)
- Bivalirudin vs Heparin in ECMO Patients (PHASE1)
- Efficacy and Safety of Bivalirudin Versus Heparin During Coil Embolization in Patients With Ruptured Intracranial Aneurysms (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bivalirudin Injection CI brief — competitive landscape report
- Bivalirudin Injection updates RSS · CI watch RSS
- Hamad Medical Corporation portfolio CI
Frequently asked questions about Bivalirudin Injection
What is Bivalirudin Injection?
Bivalirudin Injection is a Small molecule drug developed by Hamad Medical Corporation.
Who makes Bivalirudin Injection?
Bivalirudin Injection is developed and marketed by Hamad Medical Corporation (see full Hamad Medical Corporation pipeline at /company/hamad-medical-corporation).
Is Bivalirudin Injection also known as anything else?
Bivalirudin Injection is also known as anticoagulation.
What development phase is Bivalirudin Injection in?
Bivalirudin Injection is FDA-approved (marketed).
Related
- Manufacturer: Hamad Medical Corporation — full pipeline
- Also known as: anticoagulation
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing